Sunesis Pharmaceuticals, Inc. (SNSS) to Present at the Wells Fargo 2013 Healthcare Conference
6/13/2013 8:55:43 AM
More...
|
Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals, Inc. (SNSS)' VALOR Trial With No Change to Study Conduct
6/13/2013 8:53:50 AM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Appoints Steve Carchedi to Board of Directors
6/11/2013 9:10:50 AM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Release: Vosaroxin Review Published in Expert Opinion on Pharmacotherapy
5/30/2013 9:50:59 AM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Reports First Quarter Financial Results and Recent Highlights
5/9/2013 10:01:28 AM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) to Present at the Needham & Company 12th Annual Healthcare Conference
4/24/2013 12:47:42 PM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Reports Fourth Quarter and Full-Year 2012 Financial Results and Recent Highlights
3/13/2013 11:29:22 AM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) to Host Conference Call on March 13th to Discuss Fourth Quarter and Full-Year 2012 Financial Results and Recent Highlights
3/6/2013 11:16:17 AM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) Announces Clinical Trial Updates and 2013 Milestones at the 31st Annual JP Morgan Healthcare Conference
1/11/2013 9:36:55 AM
More...
|
Sunesis Pharmaceuticals, Inc. (SNSS) to Present at the J.P. Morgan Healthcare Conference
1/2/2013 9:23:11 AM
More...
|
|